BiologicsMD
Fayetteville
About BiologicsMD
BiologicsMD™ is an early stage therapeutic development company focused on developing highly-targeted or ‘smart’ therapies for the treatment of hair loss diseases and conditions, as well as severe bone disorders. The company is developing a series of recombinant fusion proteins that provide powerful stimulatory effects directly to the target receptors at the point of disease – and do so with sustained therapeutic exposure in either a single dose or very infrequent dosing regimens. The company is working on formulation and delivery vehicles that can accommodate parenteral, local, and topical administration.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $58.1K
- Last round: Corporate Round (May 2024)
- Website: biologicsmd.com
- Phone: 479.521.1997
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/biologicsmd-173623 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.